Thermo Fisher Scientific introduces the Prelude LX-4 MD HPLC, listed with the FDA as a Class I medical device for general clinical use. Clinical laboratories requiring high-throughput separations for their LC-MS assays now have access to a new four-channel, high-performance liquid chromatography (HPLC) system designed to increase the productivity and efficiency of clinical sample separations, while freeing valuable bench space. This system quadruples the productivity of a single-channel HPLC using four parallel channels that deliver up to four separations in a single instrument, streamlining LC-MS workflows, and reducing mass spectrometer idle time. The four channels can run identical or different LC-MS assays simultaneously, which provides flexibility for varying clinical separations and maximizes mass spectrometer utilization.
www.medlabmag.com uses tracking technologies. The site may also
include cookies from third parties. By continuing to use this website, you consent
to the use of tracking technologies as defined in our
Privacy Policy that can be read by clicking here.